
Dericip 115mg/35mg Tablet
Marketer
Cipla Ltd
Salt Composition
Etofylline (115mg) + Theophylline (35mg)
Overview Dericip 115mg/35mg Tablet
Airobron 115mg/35mg tablets are indicated for asthma and chronic obstructive pulmonary disease (COPD), a lung condition characterized by restricted airflow. This medication facilitates breathing by relaxing airway muscles. Airobron 115mg/35mg tablets should be taken on an empty stomach, following your physician's prescribed dosage and regimen. Dosage is individualized based on your condition and response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are currently using, as interactions are possible. Common side effects include nausea, vomiting, dyspepsia, headache, and agitation; most are transient. Report any concerning side effects to your doctor immediately. Prior to commencing treatment, disclose any pre-existing heart, kidney, or liver conditions to allow for appropriate dosage adjustment. Also inform your doctor if you are pregnant, intend to become pregnant, or are breastfeeding.
Primary Ingredients of Dericip 115mg/35mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Dericip 115mg/35mg Tablet
Managing Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Dericip 115mg/35mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Dericip 115mg/35mg tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach. Refrain from consuming caffeine or chocolate, including foods and beverages containing these substances (e.g., tea, cocoa).
Common Side effects of Dericip 115mg/35mg Tablet:
- Nausea
- Vomiting
- Headache
- Restlessness
How to use Dericip 115mg/35mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Dericip 115mg/35mg Tablet whole; do not chew, crush, or break it. Administer this tablet on an empty stomach. Refrain from consuming caffeine or chocolate (including products derived from tea leaves or cocoa beans) while taking Dericip 115mg/35mg Tablets.
How Dericip 115mg/35mg Tablet works:
Etofylline and theophylline, combined in Dericip 115mg/35mg tablets, act as dual bronchodilators. By relaxing airway muscles, they increase airflow, thereby improving breathing.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dericip 115mg/35mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dericip 115mg/35mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Dericip 115mg/35mg tablets are compatible. Research in humans indicates negligible transfer of the medication into breast milk, posing minimal risk to the infant. Postponing breastfeeding for two to four hours following Dericip 115mg/35mg tablet administration can further minimize infant exposure.
DrivingCONSULT YOUR DOCTOR
The effect of Dericip 115mg/35mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Dericip 115mg/35mg Tablet use in individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with hepatic impairment should use Dericip 115mg/35mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dericip 115mg/35mg Tablet :
Should you forget to take a Dericip 115mg/35mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dericip 115mg/35mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
